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Zulfiqar A. Bhutta,Uzrna Shah  ( Departments of Paediatrics, The Aga Khan University Medical Center. Karachi. )  
Tariq Moattar  ( Departments of Pathology, The Aga Khan University Medical Center, Karachi. ) 
Abstract  
Objective: Evaluation of the incidence of common SF508 mutation in a cohort of Pakistani 
children with Cystic Fibrosis (CF). 
Methodology: The presence of the CFTR gene mutation at position 508 (AF508) was evaluated 
in 15 consecutively presenting children with CF, proven by clinical features and an 
unequivocally positive sweat chloride test. The DNA from mononuclear cells was extracted and 
the AF508 mutation assessed by the amplification refractory mutation system using the 
polymerase chain reaction. 
Result: The AF508 mutation was found in 9 cases (60%), of which 5 were homozygous for the 
disorder. 
Conclusion: In this preliminary study, the reported frequency of the AF508 mutation in 
Pakistani children with CF is lower than the reported frequency among the Western Caucasian 
population. Further studies are needed to characterize the common genetic mutations in Pakistani 
children with CF (JPMA 50:217, 2000). 
Introduction  
Cystic fibrosis is one of the most common autosomal recessive disorders among Caucasian 
population affecting almost 1 in 2000 population1. The disorder is caused by mutations in the 
cystic fibrosis transmembrane conductance regulator (CFTR) gene on chromosome7, which 
encodes a protein of 1480 amino acid residues2. The mutations in CFTR disrupt the CAMP-
regulated chloride channel formed by CFTR and also interfere with its regulation of other ion 
channels such as the amiloride-sensitive sodium channel and the outwards rectifying chloride 
channel3. Thus specific mutations of the CFTR gene may lead to variable clinical changes and 
altered phenotype4-7. The association of some mutations with severe disease and pancreatic 
insufficiency is well organized4,5 and presently over 800 different mutations have been 
described8. 
The most common CFTR mutation recognized world wide is a three base pair deletion of the 
codon for a phenylalanine residue at amino acid position 508 (AF508) in the predicted CF 
polypeptide9,10. Although the relationship of specific mutations with recognizable disease 
patterns and phenotypes in different populations is well known11,12 there is little information on 
the genotypic patterns of CF in Asian populations. This information is important as despite 
previous considerations, CF has now been reported among Middle Eastern and South Asian 
subjects3-16. In a preliminary study Kabra et al17 evaluated13 children with CF in Delhi and found 
that 54% had the AF508 mutation. There are no published reports of genetic analysis in CF 
patients from Pakistan. We now report the preliminary results of screening for the AF508 
mutation in consecutive 15 children with proven CF from Karachi. 
Patients and Methods  
A consecutive 1 5 children (age 3 month - 9 years) with proven cystic fibrosis were included in 
this study. The diagnosis in all was based on suggestive clinical features and an unequivocally 
positive sweat chloride test. In all cases the sweat test was performed by pilocarpine 
iontophoresis on a minimum of 70 g sweat. Chloride concentration of >40 mmol/L was taken as 
diagnostic of CF12. The clinical features and outcome in this group of patients will be described 
elsewhere. 
Extraction of DNA from mononuclear cells 
For mononuclear cell isolation, 5ml blood from each patient was collected in screw cap tubes 
containing EDTA. An equal volume of saline and blood were evenly mixed and slowly poured 
on a cushion of histopaque (Sigma, USA). Following centrifugation at 400 X g for 20 min at 
room temperature, the mononuclear cell layer formed at the junction of histopaque and plasma 
was removed and transferred to a new tube. After washing once with saline the cells were used 
for DNA extraction by rapid slating out method18. Briefly, the cells were resuspended and 
homogenized in proteinase K-buffer pH 8.0 (1M NaCI, 0.1 M EDTA, 1% SDS) followed by 
addition of 10 mg/mI proteinase K to a final concentration of 500 mg/mI. The reaction mixture 
was kept at 55°C for 2 hours. 
Subsequently, the proteins were precipitated by 6 M NaCI and pelleted by centrifugation. The 
supernatant was transferred to a fresh tube and DNA was precipitated by ethanol, pelleted and 
dissolved in T.E bufferpH 7.4(10mM tris. 1mM EDTA). 
AF508 mutation analysis by Refractory Mutation System (ARMS) Amplification 
All patients were screened for the AF508 mutation using ARMS19 A typical ARMS assay 
comprises two PCRs each conducted using the same substrate DNA. For the identification of a 
specific mutation, two primers, one complementary to the normal DNA sequence and the other 
to the mutant DNA were mixed with the target DNA in separate reaction tubes. The standard 
ARMS reaction consisted of 0.5 ug DNA template, 1 uM of oligonucleotide primers (for 
sequences: Ferrie et al). 200 UM of each deoxynucleotide triphosphate and 1 .5 U Taq 
Polymerase (advance Biotechnologies, USA) in PCR buffer containing 1.5 MM MgCI2, 10 niM 
Tris pH 8.0 and 50 mM KCI. The amplification was performed for 35 cycles under the following 
conditions: 94°C denaturation for 2 min, 60°C annealing for 2 min, and 72°C extension for 2 
min. A final extension at 72°C was carried out for to min. The amplified product was separated 
in an agarose gel by electrophoresis, visualized by ethidium bromide staining and exposure to 
UV light. The presence of a 1 60 base pair specific product denoted a positive result. A positive 
and a negative control were included in each PCR reaction to monitor efficiency of PCR 
reaction, presence of PCR inhibitors in the specimen and pipetting errors. 
Results  
Of the S cases evaluated for the presence of AF508 no mutation could be identified. Of the 9 5 
were homozygous for the mutation 6 (Figure). 
 
The overall positivity rate for the AF508 mutation was 60%. 
Discussion  
Our preliminary data indicate that only a third of the patients with CF are homozygous for 
AF508 mutation, which is significantly lower than the reported frequency among the Caucasian 
population20. Previous studies on Pakistani children and families with CF in UK21,22 and 
elsewhere23 have also failed to show the AF508 mutation and a variety of other mutations have 
been described. A similar study of 216 unrelated patients with CF, including 50 South Indians, 
reported no cases of AF508 mutation24. 
Given the diversity of clinical presentation and the relationship of severe disease with specific 
genotype, it is important to clearly characterise the CF genotype among South Asians. While 
delayed presentation and diagnosis of CF has been reported previously among Asians25-27. 
Recent data indicates that the disease may also be phenotypically more severe in this ethnic 
group16,28. It is therefore important to characterise the genotype of CF among the south Asian 
populations. The other important reason is the growing necessity of genotyping in making a 
diagnosis of CF. Although the sweat chloride test has been widely used to make the definitive 
diagnosis in suspected patients. there is a well-recognised sub-group with borderline or negative 
results and the results may be negative in infancy12. It may be possible to diagnose CF in infants 
in buccal cell analysis when quantitative pilocarpine iontophoresis analysis is not possible29. 
Also given the high rates of consanguinity in Pakistan, genotyping of chorion villous sampling 
may be the only practical option for antenatal diagnosis. 
Because of the wide range of mutations in the CFTR gene, unraveling the genotype in CF among 
Asians is a daunting task. There is a clear need to set up national or regional gene banks and it 
may be cost-effective to pool resources to do so. 
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